Aaron Ondrey

Aaron Ondrey

No open positions remaining

Net worth: 393 491 $ as of 2026-05-30

50 year
Health Technology
Consumer Services

Profile

Aaron Ondrey formerly worked at Regeneron Pharmaceuticals, Inc., as Executive Director-Commercial Finance from 2010 to 2018, Mirati Therapeutics, Inc., as Chief Financial Officer & SVP-Financial Planning from 2023 to 2024, Rocket Pharmaceuticals, Inc., as Chief Financial Officer from 2024 to 2025, Alexion Pharmaceuticals, Inc., as Head-US & Global Commercial Finance, and Arena Pharmaceuticals, Inc., as Vice President-Finance.
Mr. Ondrey received his undergraduate degree from Case Western Reserve University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-07-02 128,173 ( 0.12% ) 393 491 $ 2026-05-30

Former positions of Aaron Ondrey

CompaniesPositionEnd
ROCKET PHARMACEUTICALS, INC. Director of Finance/CFO 2025-09-04
MIRATI THERAPEUTICS Director of Finance/CFO 2024-01-22
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 2018-10-31
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal -
ARENA PHARMACEUTICALS Director of Finance/CFO -
See the detail of Aaron Ondrey's experience

Training of Aaron Ondrey

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!